Skip to main content
. 2017 Jun 1;12(6):e0178035. doi: 10.1371/journal.pone.0178035

Fig 1. Kaplan-Meier plot of cumulative survival in TB disease among bDMARDs and tDMARDs treatment.

Fig 1

Others group includes golimumab, tocilizumab, abatacept and tofacitinib. P-value was determined by the log-rank test. Abrreviations: TB, tuberculosis; bDMARDS, biological drug modifying anti-rheumatic drugs; tDMARDs, targeted disease modifying anti-rheumatic drugs; ETN: etanercept; ADA: adalimumab.